Abbott Laboratories (ABT) Q3 2014 Earnings Results

Abbott Labs Misses on EPS, Stock Down 1.89%

Abbott Labs reported earnings that fell short of expectations, leading to a decline in stock price by 1.89%. The miss on EPS suggests that the company is facing some challenges, which may affect investor confidence. However, management's focus on innovation and cost management indicates they are working to navigate these issues moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.54	N/A	-9.85%

Management

Management commentary

Tone: Cautiously Optimistic

Management acknowledged the tough environment but expressed confidence in their long-term strategy. They are committed to improving operational efficiency.

Management highlighted ongoing challenges in the market.

They emphasized a focus on innovation and cost management.

Abbott Labs Misses on EPS, Stock Down 1.89%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Misses on EPS, Stock Down 1.89%

Key numbers

Management commentary